Status:
UNKNOWN
New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer
Lead Sponsor:
Regina Elena Cancer Institute
Collaborating Sponsors:
University of California, San Diego
Lega Italiana per la Lotta contro i Tumori
Conditions:
PREDICTIVE BIOMARKERS
Evaluation of HPV-specific E5 Transcript Expression in a Cohort of Patients With HPV-associated OPC
Eligibility:
MALE
18+ years
Brief Summary
The study involves the coexistence of a retrospective part, in which a group of patients with HPV-associated OPC for whom follow-up data of at least 2 years after diagnosis are available, designed in ...
Eligibility Criteria
Inclusion
- Male subjects
- age \> 18 years
- current and/or former smokers
- reporting at least 5 (Souza 2017) lifetime oral sex partners
- Written informed consent
Exclusion
- Oral pathology
- inability to understand and sign an informed consent form
Key Trial Info
Start Date :
March 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06097936
Start Date
March 15 2021
End Date
April 1 2024
Last Update
October 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
"Regina Elena" National Cancer Institute
Rome, Italy, 00144